NCT02556931
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Blood Protein Disorders, +51 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
Clinical trial condition
Myelodysplastic-Myeloproliferative Diseases
Explore clinical trials studying Myelodysplastic-Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.
384 public trials
62 recruiting studies
Myelodysplastic-Myeloproliferative Diseases trial results
NCT01736683
- Conditions
- Anemia, Bone Marrow Diseases, Chronic Disease, +16 more
- Locations
-
- Rocky Mountain Cancer Center-Midtown Denver, Colorado, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Johns Hopkins Baltimore, Maryland, United States
- Dana-Farber / Harvard Cancer Institute Boston, Massachusetts, United States
NCT02553941
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +15 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- University of California San Diego San Diego, California, United States
Completed
A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib
NCT01776723
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- Greenville Health System Little Rock, Arkansas, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Compassionate Cancer Care Medical Group Incorporated Riverside, California, United States
NCT01834248
- Conditions
- Acute Myeloid Leukemia, Alkylating Agent-Related Acute Myeloid Leukemia, Bone Marrow Diseases, +17 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
NCT00450450
- Conditions
- Bone Marrow Diseases, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, +29 more
- Locations
-
- Children's Oncology Group Arcadia, California, United States
- University of California San Francisco Medical Center-Parnassus San Francisco, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- Childrens Memorial Hospital Chicago, Illinois, United States
NCT01893320
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Completed
Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms
NCT03072043
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +17 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Weill Medical College of Cornell University New York, United States
NCT00038675
- Conditions
- Bone Marrow Diseases, Bone Marrow Neoplasms, Chronic Disease, +26 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States